16.12.2010 • NewsAlex GorskyJohnson & JohnsonPeople

Alex Gorsky and Sheri McCoy Named Vice Chairs of Johnson & Johnson Executive Committee

Johnson & Johnson promoted the heads of its medical device unit and its pharmaceuticals division to vice chairmen on Wednesday, a move that could put them in competition to succeed Chief Executive and Chairman William Weldon.

The diversified healthcare company, which has been strapped with repeated recalls of its consumer products in the past year, said Alex Gorsky - its global chairman of medical devices and diagnostics - and Sheri McCoy - global chair of pharmaceuticals - become vice chairs of the executive committee and join Weldon in an expanded office of the chairman. The moves are effective Jan. 3. Wall Street has been expecting Weldon to retire in the next year or so, although some analysts have predicted he could remain a bit longer in an attempt to put the company's troubled consumer products division back into order.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.